Biological Implants find enormous application in the fields of neurological, cardiovascular, vascular, urogenital, nephrological and orthopedic systems. They are used to treat various disorders of the above systems. Biological Implants are expected to increase productivity by identifying potential biological substitutes for the body’s repairable parts. Currently United States serves as the largest market for these biological implants. The biological implants market is segmented by Tissue/Muscle into Soft Tissue, Orthopedic, Cardiovascular, Other (includes Dental, Ophthalmic, and Urologic). By Origin these implants are segmented as Allograft and Xenograft, and by Mode of Administration into Injectable and Surgical. The biological implants industry includes companies that are engaged in biological implants’ processing, R&D, storage, banking, discovery, testing and supply of products and services and it also includes clinical research organizations. The market for biological implants displays a strong growth rate owing to the integration of biological implants into clinical trials.